Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Industry performance is calculated based on the previous closing price of all industry constituents
Largest Companies in This Industry
View MoreName | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| 113.37 | 129.76 | 23.73% | | | | Buy | |
| 356.28 | 395.59 | 16.34% | | | | Buy | |
| 84.02 | 97.09 | 14.88% | | | | Buy | |
| 89.25 | 96.07 | 13.77% | | | | Buy | |
| 67.01 | 75.08 | 4.86% | | | | Buy | |
| 70.48 | 96.33 | 3.33% | | | | Buy | |
| 221.85 | 251.59 | 2.63% | | | | Buy | |
| 106.92 | 123.72 | 2.62% | | | | Hold | |
| 231.53 | 247.64 | 1.97% | | | | Buy | |
| 17.50 | - | 1.85% | | | | Buy |
Investing in the Medical Devices Industry
Start Investing in Medical Devices Through These Companies
Top Performing Companies
View MoreName | Last Price | 1Y Target Est. | YTD Return |
|---|---|---|---|
| 17.50 | - | | |
| 15.80 | - | | |
| 11.81 | 21.78 | | |
| 6.40 | 10.50 | | |
| 10.89 | 21.33 | |
High Growth Companies
View MoreName | Last Price | Growth Estimate | YTD Return |
|---|---|---|---|
| 48.40 | | | |
| 13.57 | | | |
| 6.40 | | | |
| 13.77 | | | |
| 13.12 | | |
Medical Devices Research
View MoreDiscover the Latest Analyst and Technical Research for This Industry
Analyst Report: Zimmer Biomet Holdings, Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
RatingPrice TargetAnalyst Report: Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
RatingPrice TargetAnalyst Report: Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
RatingPrice TargetAnalyst Report: Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
RatingPrice Target
